New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Esther Oder, Martin K. Safo, Osheiza Abdulmalik, Gregory J. Kato

Research output: Contribution to journalReview article

Abstract

The hallmark of sickle cell disease is the polymerization of sickle haemoglobin due to a point mutation in the β-globin gene (HBB). Under low oxygen saturation, sickle haemoglobin assumes the tense (T-state) deoxygenated conformation that can form polymers, leading to rigid erythrocytes with impaired blood vessel transit, compounded or initiated by adhesion of erythrocytes to endothelium, neutrophils and platelets. This process results in vessel occlusion and ischaemia, with consequent acute pain, chronic organ damage, morbidity and mortality. Pharmacological agents that stabilize the higher oxygen affinity relaxed state (R-state) and/or destabilize the lower oxygen affinity T-state of haemoglobin have the potential to delay the sickling of circulating red cells by slowing polymerization kinetics. Relevant classes of agents include aromatic aldehydes, thiol derivatives, isothiocyanates and acyl salicylates derivatives. The aromatic aldehyde, 5-hydroxymethylfurfural (5-HMF) increases oxygen affinity of sickle haemoglobin and reduces hypoxia-induced sickling in vitro and protects sickle cell mice from effects of hypoxia. It has completed pre-clinical testing and has entered clinical trials as treatment for sickle cell disease. A related molecule, GBT440, has shown R-state stabilization and increased oxygen affinity in preclinical testing. Allosteric modifiers of haemoglobin as direct anti-sickling agents target the fundamental pathophysiological mechanism of sickle cell disease.

Original languageEnglish (US)
Pages (from-to)24-30
Number of pages7
JournalBritish Journal of Haematology
Volume175
Issue number1
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Keywords

  • 5-hydroxymethylfurfural
  • anti-sickling
  • GBT440
  • haemoglobin allosteric effectors
  • sickle cell
  • TD-1
  • vanillin

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?'. Together they form a unique fingerprint.

  • Cite this